Kana Mizuno

Kana Mizuno

Cincinnati Children's Hospital Medical Center - Cincinnati / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4618681
person_outline Kana Mizuno's MOST POPULAR ARTICLES
1-) Eculizumab therapy in children with severe hematopoietic stem cell transplantation–associated thrombotic microangiopathyS Jodele, T Fukuda, A Vinks, K Mizuno, BL Laskin, J Goebel, BP Dixon, ...Biology of Blood and Marrow Transplantation 20 (4), 518-525, 20142252014
2-) Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumabS Jodele, CE Dandoy, A Lane, BL Laskin, A Teusink-Cross, KC Myers, ...Blood, The Journal of the American Society of Hematology 135 (13), 1049-1057, 20201382020
3-) Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantationS Jodele, T Fukuda, K Mizuno, AA Vinks, BL Laskin, J Goebel, BP Dixon, ...Biology of blood and marrow transplantation 22 (2), 307-315, 20161372016
4-) Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin‐induced lactic acidosisK Toyama, A Yonezawa, S Masuda, R Osawa, M Hosokawa, S Fujimoto, ...British journal of pharmacology 166 (3), 1183-1191, 20121012012
5-) Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patientsK Toyama, A Yonezawa, M Tsuda, S Masuda, I Yano, T Terada, R Osawa, ...Pharmacogenetics and genomics 20 (2), 135-138, 2010602010